PedAM
Pediatric Disease Annotations & Medicines
| Disease | angina pectoris |
| Phenotype | C0010054|coronary atherosclerosis |
| Sentences | 4 |
| PubMedID- 26322175 | Several studies in human using anti-inflammatory agents and ras inhibitors revealed vascular benefits and reduced progression of coronary atherosclerosis in patients with stable angina pectoris; decreased vascular inflammatory markers, improved common carotid intima-media thickness and plaque volume in patients with diagnosed atherosclerosis. |
| PubMedID- 21262005 | Background: coronary angiography is the current standard method to evaluate coronary atherosclerosis in patients with suspected angina pectoris, but non-invasive ct scanning of the coronaries are increasingly used for the same purpose. |
| PubMedID- 21796255 | Several prospective, randomized studies show vascular benefits with olmesartan medoxomil: reduced progression of coronary atherosclerosis in patients with stable angina pectoris (olivus); decreased vascular inflammatory markers in patients with hypertension and micro- (pre-clinical) inflammation (eutopia); improved common carotid intima-media thickness and plaque volume in patients with diagnosed atherosclerosis (more); and resistance vessel remodeling in patients with stage 1 hypertension (vios). |
| PubMedID- 22386701 | Relationship between myocardial bridges and reduced coronary atherosclerosis in patients with angina pectoris. |
Page: 1